ClinicalTrials.Veeva

Menu

Asynchrony in Operated Tetralogy of Fallot (FALLOT-XI)

U

University Hospital of Bordeaux

Status

Not yet enrolling

Conditions

Tetralogy of Fallot

Treatments

Other: Electrophysiological exploration of the right ventricle

Study type

Interventional

Funder types

Other

Identifiers

NCT05485545
CHUBX 2019/39
2021-A00770-41 (Other Identifier)

Details and patient eligibility

About

The objective of this work is to estimate the correlation between the electrical activation of the VD measured by the CARTO electrophysiological mapping system and the mechanical activation of the VD measured by 3D echocardiography and 3D speckle-tracking. Our hypothesis is that there is a strong correlation between electrical activation and mechanical activation in patients with an operated Fallot tetralogy.

Full description

Fallot tetralogy is the most common cyanogenic congenital heart disease. Thanks to advances in surgery, most patients survive to adulthood but develop a failure of the function of the right ventricle and then of the left ventricle resulting in progressive heart failure and death of patients. Despite corrective surgeries in adulthood, including pulmonary valve surgery, heart failure remains a major problem. One of the mechanisms of this heart failure is the right intraventtricular asynchronism associated with the postoperative right branch block, which will secondaryly become complicated from an interventricular asynchronism for left intraventtricular, partly explaining the overall progressive failure of cardiac function. To date, there is no model for combining a combined analysis of electrical and mechanical activation in the same patients. Understanding these mechanisms would allow us to better understand the pathophysiology of heart failure in this population and to propose targeted therapies to prevent this asynchronism by adapting surgical techniques, or treating this asynchronism with electrical therapy such as bivascular resynchronization.

Each patient in each group will perform, according to standard practice, an electrophysiological exploration with mapping of the heart using the CARTO system, a cardiac MRI and a 3-dimensional transthoracic echocardiography.

The follow-up of each patient takes place during a scheduled hospitalization as part of the care. Their participation in the study only lasts for the duration of the hospitalization.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Inclusion Criteria in the Fallot group

  • Male or female patient aged 18,
  • Patient with Fallot Tetralogy operated.

nclusion Criteria in the Control group

  • Male or female patient aged 18,
  • Patient benefiting from electrophysiological exploration for a healthy heart arrhythmia,
  • Patient with a significant lack of heart disease.

Exclusion criteria

Exclusion Criteria in the Fallot group

  • Patient with associated left heart disease,
  • Patient with an acoustic window that does not allow for proper echocardiography,
  • Patient with contraindication to MRI,
  • Woman of childbearing age without effective contraception (HAS criteria) or Pregnant (ßHCG > 20 IU/l) or nursing woman.

Exclusion Criteria in the Control group

  • Patient with an acoustic window that does not allow proper echocardiography,
  • Patient with MRI contraindication,
  • Woman of childbearing age without effective contraception (HAS criteria) or Pregnant (ßHCG > 20 IU/l) or nursing woman,
  • Cardiac pathology detected during echocardiography.

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 2 patient groups

Fallot group
Other group
Description:
Patient with Fallot Tetralogy operated
Treatment:
Other: Electrophysiological exploration of the right ventricle
Control group
Other group
Description:
Patient benefiting from electrophysiological exploration for a healthy heart arrhythmia
Treatment:
Other: Electrophysiological exploration of the right ventricle

Trial contacts and locations

1

Loading...

Central trial contact

Cécile JORE; Xavier IRART, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems